Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eisai submits anticancer agent eribulin for approval in Japan, U.S. and Europe

April 1, 2010

SciClone reports topline phase II data on SCV-07 for prevention of oral mucositis

April 1, 2010

Emory University claims new noscapine analogues for cancer therapy

April 1, 2010

MMRF grants awards to Intellikine and Tragara for multiple myeloma therapies

March 31, 2010

Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine

March 31, 2010

GSK resubmits Avodart sNDA for prostate cancer to FDA

March 31, 2010

Syngene to collaborate with Endo to develop anticancer molecules

March 31, 2010

RAMBO; a new oncolytic viral therapeutic approach with potent preclinical activity

March 31, 2010

Favorable preclinical safety of bispecific MM-111 antibody for HER2-positive solid tumors disclosed

March 31, 2010

GenVec discontinues phase III PACT trial of TNFerade following interim analysis

March 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...